Translational optical imaging in diagnosis and treatment of cancer

Current Pharmaceutical Biotechnology

Volumn 13, Issue 4, 2012, Pages 498-503

  Keereweer, Stijn ^a,b   Hutteman, Merlijn ^b   Kerrebijn, Jeroen D F ^a   van de Velde, Cornelis J H ^b   Vahrmeijer, Alexander L ^b   Löwik, Clemens W G M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Image guided surgery; Near infrared fluorescence; Optical imaging; Translational research

Indexed keywords

AMINOLEVULINIC ACID; CONTRAST MEDIUM; FOLATE RECEPTOR 1; INDOCYANINE GREEN; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER SURGERY; COLORECTAL CARCINOMA; DIGESTIVE SYSTEM CANCER; FLUORESCENCE IMAGING; FLUORESCENT LIGHTING; GLIOBLASTOMA; HUMAN; IMAGING SYSTEM; LIVER CELL CARCINOMA; LIVER METASTASIS; MAMMOGRAPHY; MONITORING; NEAR INFRARED OPTICAL IMAGING; NEUROSURGERY; NONHUMAN; OPTICAL TOMOGRAPHY; OVARY CANCER; PHOTODYNAMIC THERAPY; SENTINEL LYMPH NODE; SKIN CANCER;

ANIMALS; DIAGNOSTIC IMAGING; HUMANS; LYMPH NODES; NEOPLASMS;

EID: 84857706806     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112799436294     Document Type: Article

References (46)

1. Frangioni, J. V. New technologies for human cancer imaging. J. Clin. Oncol., 2008, 26 (24), 4012-4021.
2. Leen, E.; Ceccotti, P.; Moug, S. J.; Glen, P.; MacQuarrie, J.; Angerson, W. J.; Albrecht, T.; Hohmann, J.; Oldenburg, A.; Ritz, J. P.; Horgan, P. G. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection? Ann. Surg., 2006, 243 (2), 236-240.
3. Flum, D. R.; Dellinger, E. P.; Cheadle, A.; Chan, L.; Koepsell, T. Intraoperative cholangiography and risk of common bile duct injury during cholecystectomy. JAMA, 2003, 289 (13), 1639-1644.
4. Keereweer, S.; Kerrebijn, J. D.; van Driel, P. B.; Xie, B.; Kaijzel, E. L.; Snoeks, T. J.; Que, I.; Hutteman, M.; van der Vorst, J. R.; Mieog, J. S.; Vahrmeijer, A. L.; van de Velde, C. J.; Baatenburg de Jong, R. J.; Lowik, C. W. Optical Image-guided Surgery-Where Do We Stand? Mol. Imaging Biol. 2011, 13(2),199-207.
5. Nioka, S.; Chance, B. NIR spectroscopic detection of breast cancer. Technol. Cancer Res. Treat., 2005, 4 (5), 497-512.
6. Kaijzel, E. L.; van der Pluijm, G.; Lowik, C. W. Whole-body optical imaging in animal models to assess cancer development and progression. Clin. Cancer Res., 2007, 13 (12), 3490-3497.
7. Kossodo, S.; Pickarski, M.; Lin, S. A.; Gleason, A.; Gaspar, R.; Buono, C.; Ho, G.; Blusztajn, A.; Cuneo, G.; Zhang, J.; Jensen, J.; Hargreaves, R.; Coleman, P.; Hartman, G.; Rajopadhye, M.; Duong, L. T.; Sur, C.; Yared, W.; Peterson, J.; Bednar, B. Dual in vivo quantification of integrin-targeted and protease-activated agents in cancer using fluorescence molecular tomography (FMT). Mol. Imaging Biol,. 2010, 12(5),488-499.
8. Biffi, S.; Garrovo, C.; Macor, P.; Tripodo, C.; Zorzet, S.; Secco, E.; Tedesco, F.; Lorusso, V. In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imaging. Mol. Imaging, 2008, 7 (6), 272-282.
9. Kumar, A. T.; Raymond, S. B.; Bacskai, B. J.; Boas, D. A. Comparison of frequency-domain and time-domain fluorescence lifetime tomography. Opt. Lett., 2008, 33 (5), 470-472.
10. Choi, Y.; Weissleder, R.; Tung, C. H. Selective antitumor effect of novel protease-mediated photodynamic agent. Cancer Res., 2006, 66 (14), 7225-7229.
11. Choe, R.; Konecky, S. D.; Corlu, A.; Lee, K.; Durduran, T.; Busch, D. R.; Pathak, S.; Czerniecki, B. J.; Tchou, J.; Fraker, D. L.; Demichele, A.; Chance, B.; Arridge, S. R.; Schweiger, M.; Culver, J. P.; Schnall, M. D.; Putt, M. E.; Rosen, M. A.; Yodh, A. G. Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomography. J. Biomed. Opt., 2009, 14 (2), 024020.
12. Intes, X. Time-domain optical mammography SoftScan: initial results. Acad. Radiol., 2005, 12 (8), 934-947.
13. Barrett, T.; Choyke, P. L.; Kobayashi, H. Imaging of the lymphatic system: new horizons. Contrast. Media Mol. Imaging, 2006, 1 (6), 230-245.
14. Troyan, S. L.; Kianzad, V.; Gibbs-Strauss, S. L.; Gioux, S.; Matsui, A.; Oketokoun, R.; Ngo, L.; Khamene, A.; Azar, F.; Frangioni, J. V. The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann. Surg. Oncol., 2009, 16 (10), 2943-2952.
15. Thurber, G. M.; Figueiredo, J. L.; Weissleder, R. Detection limits of intraoperative near infrared imaging for tumor resection. J. Surg. Oncol., 2010, 102(7),758-764.
16. Tanaka, E.; Choi, H. S.; Fujii, H.; Bawendi, M. G.; Frangioni, J. V. Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann. Surg. Oncol., 2006, 13 (12), 1671-1681.
17. Hama, Y.; Koyama, Y.; Urano, Y.; Choyke, P. L.; Kobayashi, H. Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity. Breast Cancer Res. Treat., 2007, 103 (1), 23-28.
18. Ohnishi, S.; Lomnes, S. J.; Laurence, R. G.; Gogbashian, A.; Mariani, G.; Frangioni, J. V. Organic alternatives to quantum dots for intraoperative near-infrared fluorescent sentinel lymph node mapping. Mol. Imaging, 2005, 4 (3), 172-181.
19. Frangioni, J. V.; Kim, S. W.; Ohnishi, S.; Kim, S.; Bawendi, M. G. Sentinel lymph node mapping with type-II quantum dots. Methods Mol. Biol., 2007, 374, 147-159.
20. Koyama, T.; Tsubota, A.; Nariai, K.; Mitsunaga, M.; Yanaga, K.; Takahashi, H. Novel biomedical imaging approach for detection of sentinel nodes in an experimental model of gastric cancer. Br. J. Surg., 2007, 94 (8), 996-1001.
21. Sevick-Muraca, E. M.; Sharma, R.; Rasmussen, J. C.; Marshall, M. V.; Wendt, J. A.; Pham, H. Q.; Bonefas, E.; Houston, J. P.; Sampath, L.; Adams, K. E.; Blanchard, D. K.; Fisher, R. E.; Chiang, S. B.; Elledge, R.; Mawad, M. E. Imaging of lymph flow in breast cancer patients after microdose administration of a nearinfrared fluorophore: feasibility study. Radiology, 2008, 246 (3), 734-741.
22. Fujiwara, M.; Mizukami, T.; Suzuki, A.; Fukamizu, H. Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: preliminary experience. J. Plast. Reconstr. Aesthet. Surg., 2009, 62 (10), e373-e378.
23. Tagaya, N.; Yamazaki, R.; Nakagawa, A.; Abe, A.; Hamada, K.; Kubota, K.; Oyama, T. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am. J. Surg., 2008, 195 (6), 850-853.
24. Kitai, T.; Inomoto, T.; Miwa, M.; Shikayama, T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer, 2005, 12 (3), 211-215.
25. Murawa, D.; Hirche, C.; Dresel, S.; Hunerbein, M. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. Br. J. Surg., 2009, 96 (11), 1289-1294.
26. Hirche, C.; Murawa, D.; Mohr, Z.; Kneif, S.; Hunerbein, M. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res. Treat., 2010, 121(2),373-378.
27. Hojo, T.; Nagao, T.; Kikuyama, M.; Akashi, S.; Kinoshita, T. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer. Breast, 2010, 19(3),210-213.
28. Noura, S.; Ohue, M.; Seki, Y.; Tanaka, K.; Motoori, M.; Kishi, K.; Miyashiro, I.; Ohigashi, H.; Yano, M.; Ishikawa, O.; Miyamoto, Y. Feasibility of a lateral region sentinel node biopsy of lower rectal cancer guided by indocyanine green using a near-infrared camera system. Ann. Surg. Oncol., 2009, 17(1),144-151.
29. Mieog, J. S.; Vahrmeijer, A. L.; Hutteman, M.; van der Vorst, J. R.; Drijfhout van, H. M.; Dijkstra, J.; Kuppen, P. J.; Keijzer, R.; Kaijzel, E. L.; Que, I.; van de Velde, C. J.; Lowik, C. W. Novel Intraoperative Near-infrared Fluorescence Camera System For Optical Image-guided Cancer Surgery. Mol. Imaging, 2010, 9 (4), 223-231.
30. Jiang, T.; Olson, E. S.; Nguyen, Q. T.; Roy, M.; Jennings, P. A.; Tsien, R. Y. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc. Natl. Acad. Sci. USA, 2004, 101 (51), 17867-17872.
31. Blum, G.; von, D. G.; Merchant, M. J.; Blau, H. M.; Bogyo, M. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat. Chem. Biol., 2007, 3 (10), 668-677.
32. Mahmood, U.; Weissleder, R. Near-infrared optical imaging of proteases in cancer. Mol. Cancer Ther., 2003, 2 (5), 489-496.
33. Wunderbaldinger, P.; Turetschek, K.; Bremer, C. Near-infrared fluorescence imaging of lymph nodes using a new enzyme sensing activatable macromolecular optical probe. Eur. Radiol., 2003, 13 (9), 2206-2211.
34. Gleysteen, J. P.; Duncan, R. D.; Magnuson, J. S.; Skipper, J. B.; Zinn, K.; Rosenthal, E. L. Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment. Cancer Biol. Ther., 2007, 6 (8), 1181-1185.
35. Lee, S. B.; Hassan, M.; Fisher, R.; Chertov, O.; Chernomordik, V.; Kramer-Marek, G.; Gandjbakhche, A.; Capala, J. Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin. Cancer Res., 2008, 14 (12), 3840-3849.
36. Withrow, K. P.; Newman, J. R.; Skipper, J. B.; Gleysteen, J. P.; Magnuson, J. S.; Zinn, K.; Rosenthal, E. L. Assessment of bevacizumab conjugated to Cy5.5 for detection of head and neck cancer xenografts. Technol. Cancer Res. Treat., 2008, 7 (1), 61-66.
37. Ogawa, M.; Kosaka, N.; Longmire, M. R.; Urano, Y.; Choyke, P. L.; Kobayashi, H. Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases. Mol. Pharm., 2009, 6(2),386-395.
38. Chen, K.; Xie, J.; Chen, X. RGD-human serum albumin conjugates as efficient tumor targeting probes. Mol. Imaging 2009, 8 (2), 65-73.
39. Jin, Z. H.; Razkin, J.; Josserand, V.; Boturyn, D.; Grichine, A.; Texier, I.; Favrot, M. C.; Dumy, P.; Coll, J. L. In vivo noninvasive optical imaging of receptor-mediated RGD internalization using self-quenched Cy5-labeled RAFT-c(-RGDfK-)(4). Mol. Imaging, 2007, 6 (1), 43-55.
40. Zhou, H.; Luby-Phelps, K.; Mickey, B. E.; Habib, A. A.; Mason, R. P.; Zhao, D. Dynamic near-infrared optical imaging of 2- deoxyglucose uptake by intracranial glioma of athymic mice. PLoS. One, 2009, 4 (11), e8051.
41. Ishizawa, T.; Fukushima, N.; Shibahara, J.; Masuda, K.; Tamura, S.; Aoki, T.; Hasegawa, K.; Beck, Y.; Fukayama, M.; Kokudo, N. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer, 2009, 115 (11), 2491-2504.
42. Themelis, G.; Yoo, J. S.; Soh, K. S.; Schulz, R.; Ntziachristos, V. Real-time intraoperative fluorescence imaging system using lightabsorption correction. J. Biomed. Opt., 2009, 14 (6), 064012.
43. Figueiredo, J. L.; Alencar, H.; Weissleder, R.; Mahmood, U. Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer. Int. J. Cancer, 2006, 118 (11), 2672-2677.
44. Nabavi, A.; Thurm, H.; Zountsas, B.; Pietsch, T.; Lanfermann, H.; Pichlmeier, U.; Mehdorn, M. Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study. Neurosurgery, 2009, 65 (6), 1070-1076.
45. Gioux, S.; Mazhar, A.; Cuccia, D. J.; Durkin, A. J.; Tromberg, B. J.; Frangioni, J. V. Three-dimensional surface profile intensity correction for spatially modulated imaging. J. Biomed. Opt., 2009, 14 (3), 034045.
46. Chance, B. Near-infrared images using continuous, phasemodulated, and pulsed light with quantitation of blood and blood oxygenation. Ann. N. Y. Acad. Sci., 1998, 838, 29-45.